These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36515822)

  • 1. Challenges and Possible Solutions to Direct-Acting Oral Anticoagulants (DOACs) Dosing in Patients with Extreme Bodyweight and Renal Impairment.
    Nwanosike EM; Sunter W; Merchant HA; Conway BR; Ansari MA; Hasan SS
    Am J Cardiovasc Drugs; 2023 Jan; 23(1):9-17. PubMed ID: 36515822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review.
    Speed V; Czuprynska J; Patel JP; Arya R
    Res Pract Thromb Haemost; 2023 Nov; 7(8):102240. PubMed ID: 38193047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations.
    van Es N; Büller HR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
    Fanikos J; Burnett AE; Mahan CE; Dobesh PP
    Am J Med; 2017 Sep; 130(9):1015-1023. PubMed ID: 28502818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The problem of underdosing with direct-acting oral anticoagulants in elderly patients with nonvalvular atrial fibrillation.
    Fernández CS; Gullón A; Formiga F
    J Comp Eff Res; 2020 May; 9(7):509-523. PubMed ID: 32329353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation at the extremes of body weight: choices and dosing.
    McCaughan GJB; Favaloro EJ; Pasalic L; Curnow J
    Expert Rev Hematol; 2018 Oct; 11(10):817-828. PubMed ID: 30148651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5 most frequently asked questions about factor Xa inhibitors.
    Wang TF; Carrier M
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):515-521. PubMed ID: 36485108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism: Use in Patients with Advanced Renal Impairment, Obesity, or Other Weight-Related Special Populations.
    Dobesh PP; Kernan MM; Lueshen JJ
    Semin Respir Crit Care Med; 2021 Apr; 42(2):233-249. PubMed ID: 33601428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose discordance of direct acting oral anticoagulants using different equations for estimating GFR: a literature review.
    Nabiee M; Dashti-Khavidaki S; Khajeh B
    Expert Rev Clin Pharmacol; 2020 Aug; 13(8):857-863. PubMed ID: 32683999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
    Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
    Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation.
    Briasoulis A; Mentias A; Mazur A; Alvarez P; Leira EC; Vaughan Sarrazin MS
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):261-272. PubMed ID: 33404923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure.
    Padrini R
    Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):1-12. PubMed ID: 30167998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis.
    Malik AH; Yandrapalli S; Shetty S; Aronow WS; Jain D; Frishman WH; Cooper HA; Panza JA;
    Europace; 2020 Mar; 22(3):361-367. PubMed ID: 31985781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of non-recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta-analysis.
    Liu X; Huang M; Ye C; Xiao X; Yan C
    Clin Cardiol; 2021 Apr; 44(4):472-480. PubMed ID: 33682184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant.
    Wadsworth D; Sullivan E; Jacky T; Sprague T; Feinman H; Kim J
    J Clin Pharm Ther; 2021 Jun; 46(3):560-570. PubMed ID: 33393699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting oral anticoagulant use at extremes of body weight: Literature review and recommendations.
    Covert K; Branam DL
    Am J Health Syst Pharm; 2020 May; 77(11):865-876. PubMed ID: 32426845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants.
    Bavalia R; Middeldorp S; Weisser G; Espinola-Klein C
    Thromb Haemost; 2020 Jun; 120(6):899-911. PubMed ID: 32492723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 pandemic on England's national prescriptions of oral vitamin K antagonist (VKA) and direct-acting oral anticoagulants (DOACs): an interrupted time series analysis (January 2019-February 2021).
    Alkhameys S; Barrett R
    Curr Med Res Opin; 2022 Jul; 38(7):1081-1092. PubMed ID: 35582854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.